Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A paradigm for oncogene complementation in human breast cancer.

M Roux-Dosseto1, P M Martin

  • 1URA CNRS 1175, Faculté de Médecine-Nord, Marseille, France.

Research in Virology
|November 1, 1989
PubMed
Summary

Amplified oncogenes like c-myc, erbB-2, and int-2 influence breast cancer progression. c-myc drives rapid spread, while erbB-2 and int-2 cause delayed relapse, impacting patient survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.

Progress in molecular biology and translational science·2016
Same author

Multiscale structural characterizations of mixed U(iv)-An(iii) oxalates (An(iii) = Pu or Am) combining XAS and XRD measurements.

Dalton transactions (Cambridge, England : 2003)·2016
Same author

A nomogram to predict individual prognosis in node-negative breast carcinoma.

European journal of cancer (Oxford, England : 1990)·2012
Same author

EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults.

European journal of neurology·2008
Same author

Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney.

Biochimica et biophysica acta·2007
Same author

The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.

Oncogene·2006

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer progression involves multiple genetic alterations, including oncogene amplification.
  • Oncogene cooperation in vitro suggests complex roles in tumorigenesis.
  • Breast cancer exhibits diverse clinical behaviors, influenced by genetic factors.

Purpose of the Study:

  • To investigate the synergistic effects of amplified c-myc, erbB-2, and int-2 oncogenes on breast cancer patient outcomes.
  • To correlate oncogene amplification patterns with disease-free survival and overall survival.
  • To identify distinct oncogene cooperation groups based on clinical behavior.

Main Methods:

  • Analysis of 143 primary breast cancer patients with 50 months of clinical follow-up.
  • Uni- and multivariate analyses to assess oncogene amplification effects.
  • Evaluation of c-myc, erbB-2, and int-2 gene copy numbers and their correlation with recurrence and survival.

Main Results:

  • c-myc amplification correlated with early recurrence and shorter survival.
  • erbB-2 and int-2 amplification were associated with later relapse, particularly when c-myc was not amplified.
  • Co-amplification of c-myc and erbB-2 shortened overall survival, with amplified effects in patients with normal int-2 copy numbers.

Conclusions:

  • Oncogene amplification patterns, including c-myc, erbB-2, and int-2, significantly impact breast cancer clinical behavior and patient prognosis.
  • Distinct oncogene combinations define complementation groups with varying impacts on disease progression and survival.
  • Findings suggest sequential activation of regulatory cascades and differential oncogene roles in tumor development.

Related Experiment Videos